Sort
4,870 grants matching “glp 1”
GLP-1 Receptor Signaling, Dopamine Homeostasis and Psychostimulant Abuse
$27,773India Reddy · Vanderbilt University · F30 · FY2015 · DA
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)
$27,395John Reilly · Albany Molecular Research, Inc. · N01 · FY2016 · NS
GLP-1 Receptor Signaling, Dopamine Homeostasis and Psychostimulant Abuse
$27,329India Reddy · Vanderbilt University · F30 · FY2014 · DA
Central Effects of Glucagon-like peptide-1 on Gustatory Reward
$27,306Carolyn E. Pritchett · Pennsylvania State Univ Hershey Med Ctr · F31 · FY2012 · DC
Intestinal satiation in Roux-en-Y gastric bypass rats: brain mechanisms and sex d
$26,564Loredana Asarian · University Of Zurich · R01 · FY2012 · DK
Design, synthesis, and characterization of Gs- and Gq-biased agonists of the Glucagon-like Peptide-1 Receptor (GLP-1R)
$26,101Kyle A Brown · University Of Wisconsin-Madison · F32 · FY2022 · HL
Training Support
$25,492Kiat Ruxrungtham · Hiv-Nat, The Thai Red Cross Aids Rch Ctr · U19 · FY2010 · AI
Stimulation of Tear Secretion by a Novel Glycoprotein
$25,450John D Sheppard · Eyerx Research, Inc. · R42 · FY2009 · EY
Training Support
$25,137Kiat Ruxrungtham · Hiv-Nat, The Thai Red Cross Aids Rch Ctr · U19 · FY2009 · AI
The International Symposium on Regulatory Peptides
$25,000Juan Enrique Rozengurt · University Of California Los Angeles · R13 · FY2008 · DK
A Novel Immunological Probiotic for Treating Inflammatory Bowel Disease
$24,936Gary Fanger · Rise Therapeutics, Llc · R44 · FY2022 · DK
Catalytic antioxidant for toxic inhaled chemicals
$23,921Carl W White · University Of Colorado Denver · U54 · FY2013 · ES
Nutrient-dependent action of glucagon and GLP-1 in glucose metabolism and insulin secretion
$23,745Sarah Marie Gray · Duke University · F32 · FY2020 · DK
Theraupeutic Candidates for Huntington's Disease: From Lead to IND
$22,725Aleksey Gregory Kazantsev · Massachusetts General Hospital · U01 · FY2011 · NS
Experimental Mouse
$22,223Natalia A Ignatenko · University Of Arizona · P30 · FY2019 · CA
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 / 1/14/16)
$22,213John Reilly · Albany Molecular Research, Inc. · N01 · FY2015 · NS
CLINICAL TRIAL: EFFECTS OF SITAGLIPTIN ON BONE TURNOVER IN PTS WITH TYPE 2 DIABE
$21,450Richard E Pratley · University Of Vermont & St Agric College · M01 · FY2009 · RR
Effect of GLP-1 on microvascular insulin responses in type 1 diabetes
$20,725Kaitlin M Love · University Of Virginia · F32 · FY2020 · DK
REGULATION OF NUTRIENT-STIMULATED INSULIN SECRETION BY GLP-1
$20,613David A. D'alessio · Cincinnati Childrens Hosp Med Ctr · M01 · FY2007 · RR
A 3-month Release Naltrexone for Addiction Treatment
$20,186Timothy D Heath · Plumb Pharmaceuticals, Inc · R43 · FY2019 · DA
EXENATIDE (BYETTA) VS PRAMLINTIDE (SYMLIN)
$19,838Rubina A Heptulla · Baylor College Of Medicine · M01 · FY2010 · RR
Development and Pre-Clinical Trial Qualification of a Pediatric Pump-Lung System for Children
$19,665Bartley Perry Griffith · University Of Maryland Baltimore · R01 · FY2019 · HL
Cellular-molecular signature and mechanism of BPA effects on penil erection
$18,838Nestor F Gonzalez-Cadavid · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U01 · FY2011 · ES
MASH Pathogenesis and Therapeutic Approaches
$16,900Terry L. Sheppard · Keystone Symposia · R13 · FY2025 · DK
Clinical Pharmacology Shared Resource
$16,667Gregory Allen Reed · University Of Kansas Medical Center · P30 · FY2018 · CA